Homepage
Welcome to the Center for Pharmacoepidemiology and Treatment Science
Established on July 1, 2017, the Rutgers Center for Pharmacoepidemiology and Treatment Science (PETS) was formed to perform and foster innovative, multidisciplinary science related to the use and outcomes of therapeutics and diagnostics in large populations. Its mission is to advance pharmacoepidemiology and related fields by conducting world-class research and facilitating high-quality training. The PETS Center brings together a strong team of committed core faculty, highly trained staff, along with colleagues from academia, industry, and regulatory agencies with expertise ranging from epidemiology, biostatistics, and biomedical informatics to clinical medicine, economics, and the social sciences.
PETS @ International Conference for Pharmacoepidemiology (ICPE)
PETS Faculty, Staff, and Trainees attended and presented their research at the 39th ICPE. The conference took place in Halifax, Canada in August 2023. PETS was involved in the teaching of skills courses, presentation of research through symposiums and workshops, and poster presentations. Click the link to discover PETS at ICPE 2023.
News from PETS
Letter from Rutgers Researchers Re: CMS Policy Changes
In response to the policy changes in data access recently announced by the Centers for Medicare and Medicaid Services (CMS), Rutgers University researchers sent a letter to CMS leadership on April 9, 2024, to emphasize how the policy changes will negatively impact health research.
Hiring: Director of PETS
Rutgers Biomedical and Health Sciences (RBHS)/Rutgers Health seeks exceptional leadership candidates to apply for the role of Director, Center for Pharmacoepidemiology and Treatment Science (Director, PETS) within the Rutgers Institute for Health, Health Care Policy and Aging Research (IFH).
Oral Medication Is the Leading Choice for Multiple Sclerosis Treatment
PETS postdoc Mackenzie Henderson publishes research on MS treatment trends.
